Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory L Krauss

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Neurology|January 13, 2005
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyGregory L Krauss
Neurology|November 7, 2008
Re: Electrographic seizures and periodic discharges after intracerebral hemorrhageGregory L Krauss
Epilepsy Currents|June 13, 2012
Which Hippocampal Sclerosis is Imaged With 7-T MRI?Gregory L Krauss
Epilepsy Currents|February 14, 2015
Should "historic control" epilepsy monotherapy trials be "history"?Gregory L Krauss
JAMA Neurology|June 28, 2017
Potential Influence of FDA-Sponsored Studies of Antiepilepsy Drugs on Generic and Brand-name Formulation PrescribingGregory L Krauss
Epilepsy Currents|December 2, 2011
Cognitive Activation of "Hyperexcitable Cortex" in JME: Can It Trigger Seizures?Gregory L Krauss
Epilepsy Currents|October 15, 2009
Evaluating risks for vigabatrin treatmentGregory L Krauss
Epilepsy & Behavior : E&B|March 1, 2003
ReplyGregory L. Krauss
Epilepsy Currents|December 19, 2013
Perampanel: a selective AMPA antagonist for treating seizuresGregory L Krauss
Neurology|September 30, 2016
More data on the safety of generic substitution: Yes, the blue tablet is OK?Gregory L Krauss, Michael Privitera
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Neurology|January 13, 2005
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyGregory L Krauss
Neurology|November 7, 2008
Re: Electrographic seizures and periodic discharges after intracerebral hemorrhageGregory L Krauss
Epilepsy Currents|June 13, 2012
Which Hippocampal Sclerosis is Imaged With 7-T MRI?Gregory L Krauss
Epilepsy Currents|February 14, 2015
Should "historic control" epilepsy monotherapy trials be "history"?Gregory L Krauss
JAMA Neurology|June 28, 2017
Potential Influence of FDA-Sponsored Studies of Antiepilepsy Drugs on Generic and Brand-name Formulation PrescribingGregory L Krauss
Epilepsy Currents|December 2, 2011
Cognitive Activation of "Hyperexcitable Cortex" in JME: Can It Trigger Seizures?Gregory L Krauss
Epilepsy Currents|October 15, 2009
Evaluating risks for vigabatrin treatmentGregory L Krauss
Epilepsy & Behavior : E&B|March 1, 2003
ReplyGregory L. Krauss
Epilepsy Currents|December 19, 2013
Perampanel: a selective AMPA antagonist for treating seizuresGregory L Krauss
Neurology|September 30, 2016
More data on the safety of generic substitution: Yes, the blue tablet is OK?Gregory L Krauss, Michael Privitera
Pageof 9